SCHEMBL1704411

SCHEMBL1704411

CSc1nc(-c2ccncc2)nc(NCCO)c1C(=O)Nc1ccc(C)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
ALDH1A1 P00352 4/20 0.43
TP53 P04637 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
LATS1 O95835 1/20 0.41
LATS2 Q9NRM7 1/20 0.41
LMNA P02545 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 2/20 0.39
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
TAS1R2 Q8TE23 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1704731 0.87 CYP3A4 (0.43) MAPTALDH1A1TP53RXFP1LATS1
SCHEMBL2952980 0.84 CCNC (0.42) ALDH1A1LATS1LATS2LMNAMEN1
SCHEMBL1704061 0.81 LATS1 (0.43) MAPTALDH1A1RXFP1LATS1LATS2
SCHEMBL2953212 0.80 LATS1 (0.43) MAPTALDH1A1TP53LATS1LATS2
SCHEMBL1704446 0.80 MAPK1 (0.44) MAPTLATS1LATS2LMNAMEN1
SCHEMBL1705388 0.79 RAB9A (0.43) MAPTALDH1A1TP53LATS1LATS2
SCHEMBL2956022 0.79 MEN1 (0.46) MAPTALDH1A1LATS1LATS2LMNA
SCHEMBL2947135 0.78 MAPT (0.46) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL4635385 0.75 MEN1 (0.40) MAPTALDH1A1LATS1LATS2LMNA
SCHEMBL2948828 0.75 RAB9A (0.42) MAPTTP53LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759350-B2 Pyrimidine carboxamides ORCHID RESEARCH LABORATORIES LTD. (IN) 2010-07-20 US claimed
EP-1931642-A2 NOVEL PYRIMIDINE CARBOXAMIDES Orchid Research Laboratories Limited (IN) 2008-06-18 EP claimed
US-20070072876-A1 Novel pyrimidine carboxamides ORCHID RESEARCH LABORATORIES LTD. (IN) 2007-03-29 US claimed
WO-2007031829-A2 NOVEL PYRIMIDINE CARBOXAMIDES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2007-03-22 WO claimed
EP-2960341-B1 NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE MOLECULAR HEALTH GMBH (DE) 2018-06-27 EP disclosed
EP-3263717-A1 NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE Molecular Health GmbH (DE) 2018-01-03 EP disclosed
US-20170315128-A1 NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE MOLECULAR HEALTH GMBH (DE) 2017-11-02 US disclosed
EP-2435581-B1 METHODS OF USE OF A NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) MOLECULAR HEALTH GMBH (DE) 2017-07-26 EP disclosed
EP-2960341-A1 NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE Molecular Health GmbH (DE) 2015-12-30 EP disclosed
EP-2492355-B1 Tissue protective erythropoietin receptor (nepor) and methods of use MOLECULAR HEALTH GMBH (DE) 2015-04-08 EP disclosed
US-20140296318-A1 NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE MOLECULAR HEALTH GMBH (DE) 2014-10-02 US disclosed
US-8357501-B2 Tissue protective erythropoietin receptor (NEPOR) and methods of use MOLECULAR HEALTH GMBH (DE) 2013-01-22 US disclosed
US-7759350-B2 Pyrimidine carboxamides ORCHID RESEARCH LABORATORIES LTD. (IN) 2010-07-20 US disclosed
US-7759350-B2 Pyrimidine carboxamides ORCHID RESEARCH LABORATORIES LTD. (IN) 2010-07-20 US disclosed
US-20090306186-A1 NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE ALEPOR GMBH & CO. KG 2009-12-10 US disclosed
EP-1931642-A2 NOVEL PYRIMIDINE CARBOXAMIDES Orchid Research Laboratories Limited (IN) 2008-06-18 EP disclosed
US-20070072876-A1 Novel pyrimidine carboxamides ORCHID RESEARCH LABORATORIES LTD. (IN) 2007-03-29 US disclosed
US-20070072876-A1 Novel pyrimidine carboxamides ORCHID RESEARCH LABORATORIES LTD. (IN) 2007-03-29 US disclosed
US-20070072876-A1 Novel pyrimidine carboxamides ORCHID RESEARCH LABORATORIES LTD. (IN) 2007-03-29 US disclosed
WO-2007031829-A2 NOVEL PYRIMIDINE CARBOXAMIDES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072876-A1 Novel pyrimidine carboxamides UACA, SI, MYLK2 MAPT 160/4885ALDH1A1 2894/4885TP53 842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.